A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)

NCT00725413 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: etonogestrel implant (Implanon)

Sponsor

Organon and Co